Insights

Following the announcement of Made Scientific’s partnership with NurExone Biologic for GMP manufactu...

Most CDMO evaluations are designed to answer one question: can this partner manufacture the product?...

One qualified iPSC bank can support large numbers of doses. That is the platform advantage, and it a...

Rethinking CAR-T Manufacturing: A Single-Step Path to Lower COGS and Higher Yield Autologous CAR-T t...

Designing an operational model for autologous T cell manufacturing is only the starting point. Execu...

From process design to patient delivery, success depends on how the manufacturing system operates un...

The decision to build in-house or partner with a CDMO is less philosophical than it appears. At its ...

MSC manufacturing appears straightforward on paper: initiate, expand, harvest, formulate, cryopreser...

When is outsourcing to a CDMO the right move?